JP2002028473A - Method for manufacturing microcapsule film of which is made airtight - Google Patents
Method for manufacturing microcapsule film of which is made airtightInfo
- Publication number
- JP2002028473A JP2002028473A JP2000216885A JP2000216885A JP2002028473A JP 2002028473 A JP2002028473 A JP 2002028473A JP 2000216885 A JP2000216885 A JP 2000216885A JP 2000216885 A JP2000216885 A JP 2000216885A JP 2002028473 A JP2002028473 A JP 2002028473A
- Authority
- JP
- Japan
- Prior art keywords
- microcapsules
- saccharide
- microcapsule
- film
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Manufacturing Of Micro-Capsules (AREA)
- Fats And Perfumes (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膜が気密化され
たマイクロカプセルの製造方法に関する。さらに詳しく
は本発明は、コアセルベーション法により調製されたマ
イクロカプセルを糖類および/または糖アルコールで被
覆することを特徴とする皮膜が気密化されたマイクロカ
プセルの製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing microcapsules in which a film is hermetically sealed. More specifically, the present invention relates to a method for producing a hermetically sealed microcapsule, which comprises coating a microcapsule prepared by a coacervation method with a saccharide and / or a sugar alcohol.
【0002】[0002]
【従来の技術】従来、マイクロカプセルの製造方法とし
て、ゼラチン−アラビアガム系等を用いたコアセルベー
ション法が知られている。コアセルベーション法は油性
液体を効率良く簡便にカプセル化することができるの
で、粘性のある油性液体をマイクロカプセル化して粉末
化するのに適している。またコアセルベーション法で製
造したマイクロカプセルは水等に溶けやすい特長を有す
るので、食品、香料、医薬の分野のマイクロカプセル化
法として特に好適に用いられる。しかしながら、コアセ
ルベーション法により調製されたマイクロカプセルは、
カプセル皮膜の気密性が不充分であり、保存中に芯物質
が揮散したり、空気酸化による変質や変色を生じる欠点
がある。このような欠点を補うため、マイクロカプセル
をエタノール、タンニン酸、カリミョウバンなどで処理
してゼラチンを架橋し、皮膜を硬化処理する方法が知ら
れている。これらの方法によれば、芯物質の揮散や変質
をある程度防止することができるがその効果は必ずしも
十分ではなく皮膜の気密性がより優れたマイクロカプセ
ルが求められている。2. Description of the Related Art Conventionally, as a method for producing microcapsules, a coacervation method using a gelatin-gum arabic system or the like has been known. The coacervation method can efficiently and easily encapsulate an oily liquid, and thus is suitable for microencapsulating a viscous oily liquid and pulverizing it. Further, microcapsules produced by the coacervation method have a feature of being easily soluble in water and the like, and thus are particularly suitably used as microcapsulation methods in the fields of foods, flavors, and medicine. However, microcapsules prepared by the coacervation method are:
There is a defect that the hermeticity of the capsule film is insufficient, the core substance is volatilized during storage, and deterioration or discoloration due to air oxidation occurs. In order to compensate for such a defect, there is known a method in which microcapsules are treated with ethanol, tannic acid, potassium alum, or the like to crosslink gelatin and harden the film. According to these methods, volatilization and alteration of the core substance can be prevented to some extent, but the effect is not always sufficient, and a microcapsule having more excellent airtightness of the film is required.
【0003】[0003]
【発明が解決しようとする課題】本発明は、コアセルベ
ーション法により調製されたマイクロカプセルのカプセ
ル皮膜を気密化し、保存中における芯物質の揮散や変質
を防止したマイクロカプセルを提供することを目的とす
る。SUMMARY OF THE INVENTION It is an object of the present invention to provide a microcapsule in which a capsule film of a microcapsule prepared by a coacervation method is hermetically sealed to prevent volatilization and deterioration of a core substance during storage. And
【0004】[0004]
【課題を解決するための手段】上記本発明の課題は、コ
アセルベーション法により調製されたマイクロカプセル
を糖類および/または糖アルコールで被覆することによ
って解決される。本発明を実施するに際して、マイクロ
カプセルはそれ自体公知のコアセルベーション法によっ
て調製される。例えば、油性芯物質をゼラチンのような
皮膜形成材料の水溶液中に45〜60℃で加え、撹拌下
に可食塩水溶液のようなコアセルベーション化剤を加
え、徐々に冷却して油粒子の周りにコアセルベートを吸
着させ、皮膜を形成硬化させる。この混合物中から形成
したマイクロカプセルを濾過などにより分離する。The object of the present invention can be attained by coating microcapsules prepared by the coacervation method with sugars and / or sugar alcohols. In practicing the present invention, the microcapsules are prepared by a coacervation method known per se. For example, an oily core substance is added to an aqueous solution of a film-forming material such as gelatin at 45 to 60 ° C., and a coacervating agent such as a saline solution is added under stirring, and the mixture is gradually cooled to a periphery of oil particles. The coacervate is adsorbed to form and harden a film. The microcapsules formed from the mixture are separated by filtration or the like.
【0005】カプセルに内包される芯物質には特に制限
はないが、揮散し易い、あるいは空気酸化を受けやすい
油性液体を用いる場合に本発明の利点が発揮される。本
発明で用いられる芯物質は、油性液体であれば特に限定
されるものではなく、例えばコーン油、大豆油、なたね
油、魚油、ラード、ヘッド等の動植物油、α−リノレン
酸、エイコサペンタエン酸、ドコサヘキサエン酸(DH
A)等の脂肪酸、脂溶性ビタミン類、油性および乳化香
料などが挙げられ、好ましくは脂溶性ビタミン類、油性
および乳化香料、特に好ましくは油性香料が用いられ
る。[0005] The core substance contained in the capsule is not particularly limited, but the advantage of the present invention is exhibited when an oily liquid which is easily volatilized or susceptible to air oxidation is used. The core substance used in the present invention is not particularly limited as long as it is an oily liquid.For example, corn oil, soybean oil, rapeseed oil, fish oil, lard, animal and vegetable oils such as head, α-linolenic acid, eicosapentaenoic acid, Docosahexaenoic acid (DH
Fatty acids such as A), fat-soluble vitamins, oily and emulsified flavors, and the like can be mentioned, and preferably fat-soluble vitamins, oily and emulsified flavors, and particularly preferably oily flavors are used.
【0006】本発明で用いられる皮膜形成材料として
は、特に限定されるものではないが、好ましくはゼラチ
ンが用いられる。ゼラチンとしては、未精製ゼラチン、
精製ゼラチン、酸分解ゼラチン、酵素分解ゼラチンなど
が例示され、特に限定されるものではないが、好ましく
は精製ゼラチンが用いられる。芯物質とゼラチンとの重
量比は特に限定されるものではないが、好ましくは10
0:1〜100:100、より好ましくは100:10
〜100:60の範囲で用いられる。この比が100:
1未満であればマイクロカプセルの皮膜が薄く、強度に
問題が生じることがあり、100:100を超えると、
マイクロカプセルの皮膜が厚く、芯物質の発現に悪影響
を与える可能性がある。The film-forming material used in the present invention is not particularly limited, but gelatin is preferably used. As gelatin, unpurified gelatin,
Examples thereof include purified gelatin, acid-decomposed gelatin, and enzyme-decomposed gelatin, and are not particularly limited. Preferably, purified gelatin is used. The weight ratio between the core substance and the gelatin is not particularly limited, but is preferably 10%.
0: 1 to 100: 100, more preferably 100: 10
It is used in the range of ~ 100: 60. This ratio is 100:
If it is less than 1, the film of the microcapsule is thin and a problem may occur in the strength.
The coating of the microcapsules is thick and may adversely affect the expression of the core substance.
【0007】本発明で用いられるコアセルベート化剤と
しては、通常のコアセルベート化に使用されるものを特
に制限なく用いることができる。特にアラビアガム、カ
ラギーナン、CMC類、有機または無機の塩からなる電
解質物質、例えば、塩化ナトリウム、塩化カリウム、塩
化マグネシウム、塩化アンモニウムのような陽イオンを
有する塩、硫酸塩、リン酸塩、炭酸塩、酢酸塩のような
陰イオンを有する塩が使用される。さらに水溶解性の液
体であって、その中の皮膜形成材料が水よりも少なく溶
解するような液体物質、例えば、エタノール、プロパノ
ールのようなアルコール類を用いることができる。As the coacervating agent used in the present invention, those used for ordinary coacervating can be used without any particular limitation. In particular, electrolyte substances consisting of gum arabic, carrageenan, CMCs, organic or inorganic salts, for example, salts with cations such as sodium chloride, potassium chloride, magnesium chloride, ammonium chloride, sulfates, phosphates, carbonates And salts having an anion such as acetate. Further, a liquid substance which is a water-soluble liquid and in which the film forming material therein is less soluble than water, for example, alcohols such as ethanol and propanol can be used.
【0008】コアセルベーションにより形成されたマイ
クロカプセルの乾燥方法は特に限定されるものではな
く、噴霧乾燥、減圧乾燥、凍結乾燥、流動層乾燥等が例
示される。好ましくは水に溶けにくいデンプン、セルロ
ース微粉、二酸化珪素などの乾燥助剤を用いた流動層乾
燥法により乾燥される。[0008] The method of drying the microcapsules formed by coacervation is not particularly limited, and examples include spray drying, reduced pressure drying, freeze drying, and fluidized bed drying. Preferably, it is dried by a fluidized bed drying method using a drying aid such as starch, cellulose fine powder, and silicon dioxide which are hardly soluble in water.
【0009】本発明において、マイクロカプセル皮膜の
被覆に用いられる糖類は、低分子の糖であれば特に限定
されることはなく、単糖類または少糖類が用いられる。
単糖類の例としてはグルコースが挙げられ、少糖類の例
としては、ガラクトース、シュークロース、マルトー
ス、ラクトース、ラクチトース、トレハロース、プルラ
ン、水飴およびシクロデキストリンなどが例示される。
これらは1種または2種以上の組み合わせを用いること
ができる。好ましくはシュークロース、ラクトース、マ
ルトース、ラクチトース、トレハロースの1種または2
種以上の組み合わせを用いる。酵母細胞壁は約30%の
β−グルカンを主成分とした糖であり本発明の被覆剤と
して使用することができる。糖アルコールの例としては
ソルビトール、キシリトール、マルチトールが挙げられ
る。In the present invention, the saccharide used for coating the microcapsule film is not particularly limited as long as it is a low-molecular saccharide, and a monosaccharide or an oligosaccharide is used.
Examples of monosaccharides include glucose, and examples of oligosaccharides include galactose, sucrose, maltose, lactose, lactose, trehalose, pullulan, starch syrup, cyclodextrin, and the like.
These can be used alone or in combination of two or more. Preferably one or two of sucrose, lactose, maltose, lactose and trehalose
Use combinations of more than one species. The yeast cell wall is a sugar containing about 30% β-glucan as a main component and can be used as the coating agent of the present invention. Examples of sugar alcohols include sorbitol, xylitol, maltitol.
【0010】上記の糖類および/または糖アルコールの
使用量は特に限定はないが、好ましくは皮膜物質の1重
量%〜100重量%、更に好ましくは、10重量%〜5
0重量%が用いられる。100%を超えた場合は、マイ
クロカプセルの流動性が損なわれ、またカプセル化率が
低下する。1%より少ない場合は、皮膜の気密性が不充
分である。The amount of the saccharide and / or sugar alcohol is not particularly limited, but is preferably 1% to 100% by weight, more preferably 10% to 5% by weight of the coating material.
0% by weight is used. If it exceeds 100%, the fluidity of the microcapsules will be impaired, and the encapsulation rate will decrease. If it is less than 1%, the airtightness of the film is insufficient.
【0011】糖類および/または糖アルコールによる被
覆は、マイクロカプセルのカプセル形成工程後であれば
マイクロカプセルの乾燥前または乾燥後の任意の段階で
行うことができる。好ましくはマイクロカプセルの乾燥
後に被覆される。被覆の方法としては、糖類および/ま
たは糖アルコールをそのまま或いは任意の濃度の水溶液
として添加されるが、好ましくは、糖類および/または
糖アルコールが液体状態の場合はそのまま、固体の場合
は30重量%程度の水溶液の状態で噴霧することにより
被覆される。この場合、マイクロカプセルの乾燥工程と
同時に行えば、製造工程が増えることなく経済的に有利
である。The coating with a saccharide and / or a sugar alcohol can be performed at any stage before or after the drying of the microcapsules as long as it is after the step of forming the microcapsules. It is preferably coated after drying the microcapsules. As a coating method, the saccharide and / or sugar alcohol is added as it is or as an aqueous solution having an arbitrary concentration. Preferably, the saccharide and / or sugar alcohol are in a liquid state, and in a solid state, 30% by weight. It is coated by spraying in the state of an aqueous solution. In this case, if it is performed simultaneously with the drying step of the microcapsules, it is economically advantageous without increasing the number of manufacturing steps.
【0012】本発明の製造方法は、例えば以下の方法に
よって好適に実施される。香味油などの油性液体をゼラ
チン水溶液中に45〜60℃で加え、攪拌下に可食性塩
水溶液を加え、徐々に冷却してエマルション粒子の周り
にコアセルベートを吸着させ硬化させた後、水溶液中か
ら形成されたマイクロカプセルを濾過などにより取り出
し、必要によりデンプンなどの乾燥助剤とともに乾燥
し、次いで糖類および/または糖アルコールの溶液を噴
霧し、乾燥することによって容易に実施される。このよ
うにして得られるマイクロカプセルは、流動性があり、
香味油などの油性液体が経日的に安定な性質を有したも
のである。次に、実施例を挙げて本発明を更に具体的に
説明する。The production method of the present invention is suitably carried out, for example, by the following method. An oily liquid such as flavor oil is added to the aqueous gelatin solution at 45 to 60 ° C., an aqueous edible salt solution is added with stirring, and the mixture is gradually cooled to adsorb coacervate around the emulsion particles and harden. The formed microcapsules are easily removed by filtration or the like, dried with a drying aid such as starch if necessary, and then sprayed with a solution of a saccharide and / or a sugar alcohol, followed by drying. The microcapsules obtained in this way have fluidity,
Oily liquids such as flavor oils have properties that are stable over time. Next, the present invention will be described more specifically with reference to examples.
【0013】[0013]
【実施例】実施例1 5%ジンジャーオイルを溶解したなたね硬化油30g
を、50℃に加温した10%ゼラチン水溶液60mLに加
え、油滴を形成させた。水を70mL添加し、ついでメタ
リン酸ナトリウム0.6gを水60mLに溶解させた塩溶
液を滴下し、滴下終了後、ゼラチン溶液を徐々に冷却
し、コアセルベートを形成させた。得られたコアセルベ
ートを濾別し、デンプンを乾燥助剤として、自然乾燥す
ることによりマイクロカプセルを45g得た(対照品
1)。この対照品1 45gに対し、1.5gのマルト
ースを含む水溶液5gを噴霧し、次いで自然乾燥するこ
とにより本発明のマイクロカプセル46gを得た。EXAMPLES Example 1 30 g of rapeseed hardened oil in which 5% ginger oil was dissolved
Was added to 60 mL of a 10% aqueous gelatin solution heated to 50 ° C. to form oil droplets. 70 mL of water was added, and then a salt solution obtained by dissolving 0.6 g of sodium metaphosphate in 60 mL of water was added dropwise. After completion of the addition, the gelatin solution was gradually cooled to form a coacervate. The obtained coacervate was separated by filtration and air-dried using starch as a drying aid to obtain 45 g of microcapsules (Control product 1). 5 g of an aqueous solution containing 1.5 g of maltose was sprayed on 145 g of this control product, followed by natural drying to obtain 46 g of the microcapsules of the present invention.
【0014】実施例2 実施例1のマルトースの代わりにトレハロースを用い、
本発明のマイクロカプセル47gを得た。 実施例3 実施例1のマルトースの代わりにグルコースを用い、本
発明のマイクロカプセル47gを得た。 実施例4 実施例1のマルトースの代わりに酵母細胞壁を用い、本
発明のマイクロカプセル45gを得た。Example 2 Using trehalose instead of maltose in Example 1,
47 g of the microcapsules of the present invention were obtained. Example 3 47 g of the microcapsules of the present invention were obtained by using glucose in place of maltose in Example 1. Example 4 Using the yeast cell wall in place of maltose of Example 1, 45 g of the microcapsules of the present invention were obtained.
【0015】試験例1 対照品1および実施例1〜4のマイクロカプセルを40
℃で1ヶ月間保存した後、それぞれのマイクロカプセル
を温水に溶解させ、遊離する油をGC定量分析し、ジン
ジャー香気成分の残存率を測定した。その結果を表1に
示す。Test Example 1 Control product 1 and microcapsules of Examples 1 to 4
After storage at 1 ° C. for one month, each microcapsule was dissolved in warm water, the released oil was subjected to GC quantitative analysis, and the residual ratio of ginger aroma components was measured. Table 1 shows the results.
【0016】[0016]
【表1】 上記表1の結果から、本発明品は対照品1に比べて香気
成分が保持され、油性液体の揮散防止に効果があること
が明らかである。[Table 1] From the results in Table 1 above, it is clear that the product of the present invention retains the aroma component as compared with the control product 1, and is effective in preventing the volatilization of the oily liquid.
【0017】参考例 10%DHAを溶解した中鎖脂肪酸トリグリセリド30
gを、50℃に加温した10%ゼラチン水溶液60mLに
加え、油滴を形成させた。水を70mL添加し、ついでメ
タリン酸ナトリウム0.6gを水60mLに溶解させた塩
溶液を滴下し、滴下終了後、ゼラチン溶液を徐々に冷却
し、コアセルベートを形成させた。得られたコアセルベ
ートを濾別し、デンプンを乾燥助剤として、自然乾燥す
ることによりマイクロカプセルを47g得た(対照品
2)。REFERENCE EXAMPLE Medium chain fatty acid triglyceride 30 in which 10% DHA is dissolved
g was added to 60 mL of a 10% aqueous gelatin solution heated to 50 ° C. to form oil droplets. 70 mL of water was added, and then a salt solution obtained by dissolving 0.6 g of sodium metaphosphate in 60 mL of water was added dropwise. After completion of the addition, the gelatin solution was gradually cooled to form a coacervate. The obtained coacervate was separated by filtration and air-dried using starch as a drying aid to obtain 47 g of microcapsules (control product 2).
【0018】実施例5 10%DHAを溶解した中鎖脂肪酸トリグリセリド30
gを、50℃に加温した10%ゼラチン水溶液60mLに
加え、油滴を形成させた。水を70mL添加し、ついでメ
タリン酸ナトリウム0.6gを水60mLに溶解させた塩
溶液を滴下し、滴下終了後、ゼラチン溶液を徐々に冷却
し、コアセルベートを形成させた。得られたコアセルベ
ートを濾別し、1.5gのトレハロースを含む水溶液5
gを噴霧した。デンプンを乾燥助剤として、自然乾燥す
ることにより本発明のマイクロカプセルを40g得た。Example 5 Medium chain fatty acid triglyceride 30 in which 10% DHA was dissolved
g was added to 60 mL of a 10% aqueous gelatin solution heated to 50 ° C. to form oil droplets. 70 mL of water was added, and then a salt solution obtained by dissolving 0.6 g of sodium metaphosphate in 60 mL of water was added dropwise. After completion of the addition, the gelatin solution was gradually cooled to form a coacervate. The obtained coacervate was filtered off, and an aqueous solution 5 containing 1.5 g of trehalose was added.
g was sprayed. The starch was air-dried using starch as a drying aid to obtain 40 g of the microcapsules of the present invention.
【0019】実施例6 10%DHAを溶解した中鎖脂肪酸トリグリセリド30
gを、50℃に加温した10%ゼラチン水溶液60mLに
加え、油滴を形成させた。水を70mL添加し、ついでメ
タリン酸ナトリウム0.6gを水60mLに溶解させた塩
溶液を滴下し、滴下終了後、ゼラチン溶液を徐々に冷却
し、コアセルベートを形成させた。得られたコアセルベ
ートを濾別し、デンプンを乾燥助剤として乾燥させた。
乾燥マイクロカプセルに、1.5gのソルビトールを含
む水溶液5gを噴霧した。デンプンを乾燥助剤として、
自然乾燥することにより本発明のマイクロカプセルを4
3g得た。Example 6 Medium chain fatty acid triglyceride 30 in which 10% DHA was dissolved
g was added to 60 mL of a 10% aqueous gelatin solution heated to 50 ° C. to form oil droplets. 70 mL of water was added, and then a salt solution obtained by dissolving 0.6 g of sodium metaphosphate in 60 mL of water was added dropwise. After completion of the addition, the gelatin solution was gradually cooled to form a coacervate. The resulting coacervate was filtered off and dried using starch as a drying aid.
5 g of an aqueous solution containing 1.5 g of sorbitol was sprayed on the dried microcapsules. Using starch as a drying aid
By air drying, the microcapsules of the present invention
3 g were obtained.
【0020】実施例7 10%DHAを溶解した中鎖脂肪酸トリグリセリド30
gを、50℃に加温した10%ゼラチン水溶液60mLに
加え、油滴を形成させた。水を70mL添加し、ついでメ
タリン酸ナトリウム0.6gを水60mLに溶解させた塩
溶液を滴下し、滴下終了後、ゼラチン溶液を徐々に冷却
し、コアセルベートを形成させた。得られたコアセルベ
ートを濾別し、0.25gの酵母細胞壁を含む水溶液5
gを噴霧した。デンプンを乾燥助剤として、自然乾燥す
ることにより本発明のマイクロカプセルを40g得た。Example 7 Medium-chain triglyceride 30 containing 10% DHA
g was added to 60 mL of a 10% aqueous gelatin solution heated to 50 ° C. to form oil droplets. 70 mL of water was added, and then a salt solution obtained by dissolving 0.6 g of sodium metaphosphate in 60 mL of water was added dropwise. After completion of the addition, the gelatin solution was gradually cooled to form a coacervate. The obtained coacervate was separated by filtration, and an aqueous solution 5 containing 0.25 g of yeast cell wall was obtained.
g was sprayed. The starch was air-dried using starch as a drying aid to obtain 40 g of the microcapsules of the present invention.
【0021】試験例2 対照品2及び実施例5〜7のマイクロカプセルを40
℃、3週間の加温虐待保存後、マイクロカプセルよりD
HAを回収し、それぞれのPOV値(過酸化物価)を測
定した。虐待保存した場合と5℃で3週間冷蔵保存した
場合とをそれぞれ比較した結果を表2に示した。Test Example 2 Control product 2 and the microcapsules of Examples 5 to 7
After heating and abuse storage for 3 weeks at ℃, D from microcapsules
HA was recovered, and each POV value (peroxide value) was measured. Table 2 shows the results of comparison between the case of abused storage and the case of refrigerated storage at 5 ° C. for 3 weeks.
【0022】[0022]
【表2】 上記表2の結果から、本発明のマイクロカプセルは、対
照品2のマイクロカプセルに比べて虐待保存時のDHA
のPOV値上昇率が抑えられ、DHAの酸化が防止され
ていることがわかる。[Table 2] From the results shown in Table 2 above, the microcapsules of the present invention were compared with the microcapsules of control product 2 in DHA during abuse storage.
It can be seen that the increase rate of the POV value was suppressed and the oxidation of DHA was prevented.
【0023】[0023]
【発明の効果】本発明によれば、皮膜が気密化されたマ
イクロカプセルの製造方法が提供される。本発明のマイ
クロカプセルにおいては、皮膜が糖類および/または糖
アルコールにより被覆されているので、カプセルの皮膜
が気密化されており、油性液体である芯物質の揮散や空
気酸化による変質、変色が防止される。従って芯物質と
して油性香料を用いた場合には香気成分の保持に優れ、
また酸化を受けやすい医薬成分などを用いた場合には保
存安定性に優れている。According to the present invention, there is provided a method for producing a microcapsule in which a film is hermetically sealed. In the microcapsule of the present invention, since the film is coated with a saccharide and / or a sugar alcohol, the film of the capsule is airtight, and deterioration and discoloration due to volatilization of the oily liquid core material and air oxidation are prevented. Is done. Therefore, when an oily fragrance is used as the core substance, the retention of the fragrance component is excellent,
Also, when a pharmaceutical component or the like which is easily oxidized is used, the storage stability is excellent.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C076 AA63 DD38H DD67H EE30H GG27 GG36 4G005 AA01 AB03 AB21 BA05 BB24 DA14W DB02X DB06Y DB06Z DB12Y DB12Z DB14W DB16W DB23X DB25Y DB25Z EA03 EA05 ──────────────────────────────────────────────────続 き Continued from the front page F term (reference) 4C076 AA63 DD38H DD67H EE30H GG27 GG36 4G005 AA01 AB03 AB21 BA05 BB24 DA14W DB02X DB06Y DB06Z DB12Y DB12Z DB14W DB16W DB23X DB25Y DB25Z EA03 EA05
Claims (5)
マイクロカプセルを糖類および/または糖アルコールで
被覆することを特徴とする皮膜が気密化されたマイクロ
カプセルの製造方法。1. A method for producing a hermetically sealed microcapsule, comprising coating a microcapsule prepared by a coacervation method with a saccharide and / or a sugar alcohol.
からなる群から選択された1種または2種以上の組み合
わせである請求項1記載のマイクロカプセルの製造方
法。2. The method for producing microcapsules according to claim 1, wherein the saccharide is one or a combination of two or more selected from the group consisting of monosaccharides, oligosaccharides and yeast cell walls.
のマイクロカプセルの製造方法。3. The method for producing microcapsules according to claim 2, wherein the monosaccharide is glucose.
ス、マルトース、ラクトース、トレハロース、プルラ
ン、水飴およびシクロデキストリンから選択された1種
または2種以上の組み合わせである請求項2記載のマイ
クロカプセルの製造方法。4. The method for producing microcapsules according to claim 2, wherein the oligosaccharide is one or a combination of two or more selected from galactose, sucrose, maltose, lactose, trehalose, pullulan, syrup and cyclodextrin.
ールおよびマルチトールから選択された1種または2種
以上の組み合わせである請求項1記載のマイクロカプセ
ルの製造方法。5. The method for producing microcapsules according to claim 1, wherein the sugar alcohol is one or a combination of two or more selected from sorbitol, xylitol and maltitol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000216885A JP4695248B2 (en) | 2000-07-18 | 2000-07-18 | Method for producing microcapsules with airtight coating |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000216885A JP4695248B2 (en) | 2000-07-18 | 2000-07-18 | Method for producing microcapsules with airtight coating |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002028473A true JP2002028473A (en) | 2002-01-29 |
JP4695248B2 JP4695248B2 (en) | 2011-06-08 |
Family
ID=18712074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000216885A Expired - Lifetime JP4695248B2 (en) | 2000-07-18 | 2000-07-18 | Method for producing microcapsules with airtight coating |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4695248B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002088246A1 (en) * | 2001-04-26 | 2002-11-07 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Molded object having high pullulan content, process for producing the same, and use thereof |
JP2009506106A (en) * | 2005-08-30 | 2009-02-12 | フイルメニツヒ ソシエテ アノニム | Encapsulated active ingredient, process for producing and use of encapsulated active ingredient |
JP2010504282A (en) * | 2006-06-05 | 2010-02-12 | オーシャン ニュートリッション カナダ リミテッド | Microcapsules with improved shell |
JP2013507909A (en) * | 2009-10-14 | 2013-03-07 | フイルメニツヒ ソシエテ アノニム | Solid capsules comprising a coating provided by ethanol, carbohydrates, salts and powdering agent, a process for producing the capsules by spray drying |
RU2496481C2 (en) * | 2008-11-10 | 2013-10-27 | Колгейт-Палмолив Компани | Storage-stable capsules |
US8900630B2 (en) | 2002-11-04 | 2014-12-02 | Dsm Nutritional Products | Microcapsules having multiple shells and method for the preparation thereof |
US10166196B2 (en) | 2007-01-10 | 2019-01-01 | Dsm Nutritional Products Ag | Vegetarian microcapsules |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102972726A (en) * | 2012-11-26 | 2013-03-20 | 天津科技大学 | Preparation method for temperature-controlled instantaneously-released ginger volatile oil microcapsules |
CN105831784B (en) * | 2016-04-07 | 2018-01-23 | 中国农业大学 | A kind of microencapsulation chitosan oligosaccharide and its preparation method and application |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5894387A (en) * | 1981-11-27 | 1983-06-04 | Sato Shokuhin Kogyo Kk | Preparation of alcohol-containing powder |
JPS5941395A (en) * | 1982-09-01 | 1984-03-07 | マルハ株式会社 | Stabilization of fish oils |
JPS63173568A (en) * | 1987-01-14 | 1988-07-18 | Nippon Oil & Fats Co Ltd | Double coated powder fats and oils |
JPH05292899A (en) * | 1991-06-24 | 1993-11-09 | Ajinomoto Co Inc | Production of microcapsule |
JPH09202727A (en) * | 1995-11-20 | 1997-08-05 | Kao Corp | Capsule particle excellent in solubility |
JPH10136912A (en) * | 1996-11-08 | 1998-05-26 | Morikawa Kenkoudou Kk | Production of microcapsule |
JPH10276757A (en) * | 1997-04-09 | 1998-10-20 | Haarmann & Reimer Gmbh | Alcohol-containing granular material |
JPH11269094A (en) * | 1998-01-16 | 1999-10-05 | Takeda Chem Ind Ltd | Sustained release composition, its production and use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3179877B2 (en) * | 1992-08-06 | 2001-06-25 | 長谷川香料株式会社 | Gelatin / neutral polysaccharide microcapsules and their production |
JP4473380B2 (en) * | 1999-10-20 | 2010-06-02 | 小川香料株式会社 | Method for producing dry microcapsules |
-
2000
- 2000-07-18 JP JP2000216885A patent/JP4695248B2/en not_active Expired - Lifetime
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5894387A (en) * | 1981-11-27 | 1983-06-04 | Sato Shokuhin Kogyo Kk | Preparation of alcohol-containing powder |
JPS5941395A (en) * | 1982-09-01 | 1984-03-07 | マルハ株式会社 | Stabilization of fish oils |
JPS63173568A (en) * | 1987-01-14 | 1988-07-18 | Nippon Oil & Fats Co Ltd | Double coated powder fats and oils |
JPH05292899A (en) * | 1991-06-24 | 1993-11-09 | Ajinomoto Co Inc | Production of microcapsule |
JPH09202727A (en) * | 1995-11-20 | 1997-08-05 | Kao Corp | Capsule particle excellent in solubility |
JPH10136912A (en) * | 1996-11-08 | 1998-05-26 | Morikawa Kenkoudou Kk | Production of microcapsule |
JPH10276757A (en) * | 1997-04-09 | 1998-10-20 | Haarmann & Reimer Gmbh | Alcohol-containing granular material |
JPH11269094A (en) * | 1998-01-16 | 1999-10-05 | Takeda Chem Ind Ltd | Sustained release composition, its production and use |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002088246A1 (en) * | 2001-04-26 | 2002-11-07 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Molded object having high pullulan content, process for producing the same, and use thereof |
US7749538B2 (en) | 2001-04-26 | 2010-07-06 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Molded object having high pullulan content, process for the producing the same, and use thereof |
US8900630B2 (en) | 2002-11-04 | 2014-12-02 | Dsm Nutritional Products | Microcapsules having multiple shells and method for the preparation thereof |
JP2009506106A (en) * | 2005-08-30 | 2009-02-12 | フイルメニツヒ ソシエテ アノニム | Encapsulated active ingredient, process for producing and use of encapsulated active ingredient |
JP2010504282A (en) * | 2006-06-05 | 2010-02-12 | オーシャン ニュートリッション カナダ リミテッド | Microcapsules with improved shell |
JP2013129674A (en) * | 2006-06-05 | 2013-07-04 | Ocean Nutrition Canada Ltd | Microcapsule with improved shell |
US9056058B2 (en) | 2006-06-05 | 2015-06-16 | Dsm Nutritional Products | Microcapsules with improved shells |
US10166196B2 (en) | 2007-01-10 | 2019-01-01 | Dsm Nutritional Products Ag | Vegetarian microcapsules |
RU2496481C2 (en) * | 2008-11-10 | 2013-10-27 | Колгейт-Палмолив Компани | Storage-stable capsules |
US9480631B2 (en) | 2008-11-10 | 2016-11-01 | Colgate-Palmolive Company | Shelf stable capsules |
JP2013507909A (en) * | 2009-10-14 | 2013-03-07 | フイルメニツヒ ソシエテ アノニム | Solid capsules comprising a coating provided by ethanol, carbohydrates, salts and powdering agent, a process for producing the capsules by spray drying |
Also Published As
Publication number | Publication date |
---|---|
JP4695248B2 (en) | 2011-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1454534B2 (en) | Microcapsules and oral compositions containing the same | |
JP5500705B2 (en) | Continuous multi-microencapsulation method for improving the stability and shelf life of biologically active ingredients | |
EP1443968B1 (en) | Edible film | |
EP2825057B1 (en) | Oxidixable fatty acid composition delivery form | |
JP2007521135A5 (en) | ||
EP2986141B1 (en) | Encapsulation of an oil containing unsaturated fatty acids | |
JP2005523346A (en) | Spray-dried composition and method for producing the same | |
JPH02103289A (en) | Microencapsulation of fish oil | |
EP0701815B1 (en) | Process for producing powders, granulates or pellets containing active substances and a structure consisting of hydrophilic macromolecules, and use thereof | |
JP4695248B2 (en) | Method for producing microcapsules with airtight coating | |
JP4109804B2 (en) | Method for producing flavor oil-containing microcapsules | |
Fahrurrozi et al. | Microencapsulation technology of ginger oleoresin with chitosan as wall material: a review | |
Mohammadi et al. | Design and evaluation of the release characteristics of caffeine-loaded microcapsules in a medicated chewing gum formulation | |
US6984449B2 (en) | Pellets and process for production thereof | |
JP4473380B2 (en) | Method for producing dry microcapsules | |
US20040121154A1 (en) | Pellets and process for production thereof | |
JP2005211024A (en) | Tableted product added with compression-resistant flavor preparation | |
JP2001238611A (en) | Sugar-coated seamless capsule containing water-soluble material as content | |
Khanum et al. | Nanoencapsulation of Flavors: Advantages and Challenges | |
JP2005306777A (en) | Particulate formulation containing agar | |
EP1935410A1 (en) | Microcapsules | |
JP2005137322A (en) | Candy added with heat-resistant spice pharmaceutical preparation | |
KR200297529Y1 (en) | Fruitjuice-contained Micro-capsule coated by algae extract | |
TH2001004923A (en) | Products made into microcapsules, clear solutions thereof and methods for making them | |
EP1266580A1 (en) | Sequential flavour release |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070531 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100202 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100402 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20100402 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100402 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101116 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110111 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110201 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110225 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140304 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4695248 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |